Detalhe da pesquisa
1.
Symptom Duration and Resolution With Early Outpatient Treatment of Convalescent Plasma for Coronavirus Disease 2019: A Randomized Trial.
J Infect Dis
; 227(11): 1266-1273, 2023 05 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-36722044
2.
Transfusing Convalescent Plasma as Post-Exposure Prophylaxis Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Double-Blinded, Phase 2 Randomized, Controlled Trial.
Clin Infect Dis
; 76(3): e477-e486, 2023 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35579509
3.
Transfusion reactions associated with COVID-19 convalescent plasma in outpatient clinical trials.
Transfusion
; 63(9): 1639-1648, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37534607
4.
The Effects of Four Doses of Vitamin D Supplements on Falls in Older Adults : A Response-Adaptive, Randomized Clinical Trial.
Ann Intern Med
; 174(2): 145-156, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33284677
5.
Escitalopram for agitation in Alzheimer's disease (S-CitAD): Methods and design of an investigator-initiated, randomized, controlled, multicenter clinical trial.
Alzheimers Dement
; 15(11): 1427-1436, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31587995
6.
Cardiovascular safety signals with dipeptidyl peptidase-4 inhibitors: A disproportionality analysis among high-risk patients.
Pharmacoepidemiol Drug Saf
; 27(6): 660-667, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29655237
7.
Building the Future of Environmental Public Health Tracking: Proceedings and Recommendations of an Expert Panel Workshop.
J Environ Health
; 79(10): 14-9, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29154528
8.
Losartan in hospitalized patients with COVID-19 in North America: An individual participant data meta-analysis.
Medicine (Baltimore)
; 102(23): e33904, 2023 Jun 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37335665
9.
Early Treatment, Inflammation and Post-COVID Conditions.
medRxiv
; 2023 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36824860
10.
Early antibody treatment, inflammation, and risk of post-COVID conditions.
mBio
; 14(5): e0061823, 2023 Oct 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37724870
11.
Hydroxychloroquine/chloroquine for the treatment of hospitalized patients with COVID-19: An individual participant data meta-analysis.
medRxiv
; 2022 Aug 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35043124
12.
Hydroxychloroquine/chloroquine for the treatment of hospitalized patients with COVID-19: An individual participant data meta-analysis.
PLoS One
; 17(9): e0273526, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36173983
13.
Dipeptidyl peptidase-4 inhibitor cardiovascular safety in patients with type 2 diabetes, with cardiovascular and renal disease: a retrospective cohort study.
Sci Rep
; 11(1): 16637, 2021 08 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34404825
14.
Natural vs. programmed cycles for frozen embryo transfer: study protocol for an investigator-initiated, randomized, controlled, multicenter clinical trial.
Trials
; 22(1): 660, 2021 Sep 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34579768
15.
Randomized controlled trial transfusing convalescent plasma as post-exposure prophylaxis against SARS-CoV-2 infection.
medRxiv
; 2021 Dec 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34931202
16.
Dipeptidyl peptidase-4 inhibitors and cardiovascular events in patients with type 2 diabetes, without cardiovascular or renal disease.
PLoS One
; 15(10): e0240141, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33057387
17.
Factors associated with disease severity and mortality among patients with COVID-19: A systematic review and meta-analysis.
PLoS One
; 15(11): e0241541, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33206661
18.
Erratum for Gebo et al., "Early antibody treatment, inflammation, and risk of post-COVID conditions".
mBio
; 15(1): e0297923, 2024 Jan 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38095433
19.
Association Between Sodium-Glucose Cotransporter 2 Inhibitors and Lower Extremity Amputation Among Patients With Type 2 Diabetes.
JAMA Intern Med
; 178(9): 1190-1198, 2018 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30105373
20.
Maximizing the Post-Approval Safety of Flibanserin: A Role for Regulators, Clinicians, and Patients.
Drug Saf
; 39(5): 375-80, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26798050